Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravir
Merck said Monday it is looking for US FDA (Food and Drug Administration) emergency procedure approval for its investigational antiviral Covid-19 treatment, molnupiravir. If approval is granted, the drug, prepared by Merck and Ridgeback Biotherapeutics, would be the first-ever oral antiviral treatment to fight Covid-19. It approaches in capsule form. Merck’s statement on FDA approval … Read More